HNF1A-Maturity-Onset Diabetes of the Young (MODY) in a Family With a Rare Silent Variant: Clinical Challenges and Variable Expressivity. [PDF]
Carvalho R, Moreira B, Parente S.
europepmc +1 more source
Empagliflozin in HNF1A-MODY (MODY3): A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. [PDF]
Maagensen H +11 more
europepmc +1 more source
Defective HNF1A hinders GLI3 processing favoring duodenal versus pancreatic fate, thus leading to intestinal elongation in vivo. [PDF]
Unger L +11 more
europepmc +1 more source
Hyperglycemia Due to HNF1A-Mutation-Associated Maturity-Onset Diabetes of the Young (MODY) in a 6-Year-Old Kazakh Girl. [PDF]
Toleuzhanova AB +4 more
europepmc +1 more source
Long non-coding RNAs as molecular links and circulating biomarkers between type 2 diabetes and colorectal cancer: focus on shared signaling pathways, epigenetic regulation, and ubiquitination mechanisms. [PDF]
Wu L, Meng Q, Zhou Y.
europepmc +1 more source
Hnf1aos1 as a Metabolic Coordinator of Hepatic Lipid Homeostasis and Feedback Control. [PDF]
Armanios B +7 more
europepmc +1 more source
Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer. [PDF]
Laise P +26 more
europepmc +1 more source
Long non-coding RNAs in the crosstalk between diabetes and colorectal cancer: molecular mechanisms and endocrine pathways. [PDF]
Zhang L, Li M.
europepmc +1 more source
Molecular impact of a novel <i>HNF1B</i> missense variant in childhood-onset MODY5: a case report and functional study. [PDF]
Umeda C +6 more
europepmc +1 more source
Digenic HNF1A and ABCC8 variants provide mechanistic insight into early-onset diabetes.
Honda M +8 more
europepmc +1 more source

